• Increase font size
  • Default font size
  • Decrease font size
home | about us | contact us
Search
Search Only:

Search Keyword extreme

Total: 50 results found.

... brand Actimel(R), which is an extremely popular probiotic product in Europe has been successfully launched in the United States in 2005 under the brand name DanActive(R). Still Europe is the leader in ...
... Inc., and CallForceOne Consulting Group. Gierhart commented, "Betsy understands the needs of our customers extremely well and we're excited to expand her responsibilities within the ZeaVision business." ...
... Bioscience's management team. "I am extremely pleased to welcome two distinguished executives of the biotechnology ...
... Whitening, announces $40,000 in Q1-2010 revenue. The Company is extremely pleased with this number... as it almost matches the sales for Q3 & Q4-2009 COMBINED!All during the weakest selling season ...
... people with extreme disabilities to communicate. The device detects eye movement, jaw contractions and ALPHA and BETA brain waves allowing hands free input. Neural Communicator is intended for people ...
... bottle label will help the pharmacist refill your medicine once you arrive at your destination. Heat, humidity and sunlight can degrade the effectiveness of medicine, so try to protect it from extreme ...
... survival data from the ACTII trial will be published when the median is reached, which is extremely encouraging given the trial length to-date. Phase 2b trial initiation in 3Q2010 of CDX-011: CDX-011 ...
... to the global retina community at a number of major international ophthalmology congresses. Given the success of the overall Phase III clinical program, I am extremely confident that microplasmin has the ...
...  According to Dr. Edward T. Maggio, CEO of Aegis Therapeutics, "Aggregation-induced immunogenicity is a problem for many protein therapeutics, reducing drug effectiveness and in extreme instances, causing ...
... now the Court of Appeals. Protection of intellectual property rights is extremely important to the biopharmaceutical industry and the patients we serve. We will continue to vigorously defend our rights, ...
... Western Region and Thomas Vasicek, Ph.D., as Vice President Clinical Programs and Product Innovation. “I am extremely excited to add two new members to the HTG leadership team in John Wineman ...
... e-commerce solution." "We are extremely pleased to be partnering with Montel Williams to help drive online sales through our innovative new approach to e-commerce," said Matthew Papish, CEO, Cinsay, Inc."He ...
... "Extraction is unbiased and extremely efficient, and it works on all yeasts grown in any medium. This kit is suitable for just about any yeast proteome work and will be especially appreciated by researchers ...
... of the pharmaceutical industry through consulting services. "I am extremely pleased to welcome Bernard Dubois ...
... about therapy or a question related to their insurance, the team at MS LifeLines is here to help lend a hand," added Lauren Sweeney, patient support team member at MS LifeLines.  "It is extremely ...
... GrowthWorks Capital, and BDC Venture Capital.   "We are extremely pleased to attract a new investor of this ...
...  "We are extremely pleased to welcome Bob Noel to our team and look forward to the value he'll bring our clients in their implementation of our solutions," said StayWell Custom Communications president ...
...  “At Saint Barnabas Medical Center, we see over 84,000 emergency department patients each year. The AutoPulse is extremely useful in Code Blue situations since it is easy to apply and fit to the patient. ...
... Mumper's in-depth expertise in trans-mucosal drug delivery and formulation and engineering of nanoparticles will be extremely relevant to enGene's current research direction, as we embark on developing ...
... sciences industry," said Mark Edwards, managing director of Deloitte Recap LLC. "Sanofi-aventis is extremely honored to have received the Allicense 2010 Deal of the Year Award for the Exelixis transaction," ...
... a promising target for novel therapeutics to ease the burden of the disease, according to Dr. Dodick. Although researchers have in the past described genetic mutations giving rise to rare and extreme ...
... biotechnology and food safety industries as well as related projects for business and government. “I am extremely proud to be appointed to this position, and recognize both the challenges and opportunities ...
... clinicians to constantly log-on to and off of shared workstations.And privacy regulations are extremely strict," said David Ting, founder and CTO of Imprivata."Our combined solution allows clinicians to ...
24. Shares now at substantially cheaper levels
(Premium Content/Subscriber Only Content)
... range of $40-50 million, adding significant value to CLDX. Additionally, Phase 2 overall survival data from the ACTII trial will be published when the median is reached, which is extremely encouraging ...
... will be a valuable asset for the growth and the promotion of the Gummy Bear. The domestic nutrition product market for children is extremely large and we believe that the cooperation with Nepstar will ...
... professional and home healthcare diagnostic products are extremely easy to use, while providing accurate results in less than one second. Forward Looking Statements This press release may contain ...
... "The facilities will be extremely self-sufficient. In addition to eliminating costs associated with outside sources of fossil fuels, power and process water, our technology eliminates the need for extensive ...
... of Pluristem’s PLX cells may prevent or delay the development of this extremely common but devastating disease. "There has been a growing interest in the potential of PLX cells to treat a variety of ...
... of the King Leadership Team, reporting directly to Brian Markison, Chairman, President and Chief Executive Officer of King. "We are extremely pleased that Jeff has decided to join our team," stated Mr. ...
... commence enrollment. "We are extremely pleased with the outcome of these meetings. We recognize the care and prudence ...
...  "This is extremely good and unanticipated news; summer historically sees a bit of a down-turn in the beauty sector, as people are busy with vacations and back-to-school preparations. But savvy business ...
... Having redefined spine surgery with the MAS platform's lateral approach, known as eXtreme Lateral Interbody Fusion, or XLIF®, NuVasive has built an entire spine franchise.With over 55 products today ...
... 2010. The Company's CEO, Douglas Francis, stated, "The Company is extremely excited with the expansion of our health and beauty model to now include the medical marijuana segment of health care. This ...
... Adult Stem Cell Therapy program, declaring it an extremely effective solution to treat degenerative diseases and conditions. Scientists and medical researchers worldwide are finding adult stem cells ...
... application in the most extreme operating environments to Measure Life.... Anywhere!  ...
... Adult Stem Cell Therapy program, declaring it an extremely effective solution to treat degenerative diseases and conditions. Scientists and medical researchers worldwide are finding ...
... release in the United States during the third quarter.  We have received extremely positive feedback from U.S. physicians on the new sizes and PowerFit, which gives us confidence that these new devices ...
...  Mike Tomas, Bioheart's President and Chief Executive Officer added, "We are extremely excited about the Center of Excellence established in Mexico ...
... certified and are extremely excited about the growth opportunities that this relationship brings." About Zephyr Technology Zephyr Technology is a global leader in real-time physiological and biomechanical ...
... to have an eating disorder." Cutting may be increasing in our culture because young women today are struggling with identity issues and dealing with challenging problems.They feel they have to go to extremes ...
... filled in the United States," said Shawn Brown, GPhA Vice President of State Government Affairs. "This makes it extremely important to us to do all we can to ensure the sustainability of the supply chain ...
... technology. "We are extremely pleased that Tritech Ltd. has agreed to represent us in Israel. Tritech is a well-known and established stocking representative and distributor of electronic components in ...
... newly-approved treatment for insomnia characterized by difficulty with sleep maintenance. “We are extremely excited to add Procter & Gamble’s highly regarded and tenured professional ...
... of sodium channels in chronic pain conditions.Tetrodotoxin is extremely potent, and much lower dosages are needed to produce an analgesic effect than with other drugs. About WEX Pharmaceuticals Inc. ...
... Bay Area (RSC) is hoping to recruit 150 women suffering from uterine fibroids, benign tumors that can cause extreme pain and infertility.  ...
... CAD software, which resulted in FDA clearance for iCAD. “We are very excited about receiving this FDA clearance for our CAD software, VeraLook. The partnership with ACR Image Metrix was extremely ...
...  common human diseases. But it is extremely important that we approach this task in a way that not only enables great science, but that also leads to measurable improvements in people's lives. I look ...
... date has been extremely encouraging and we expect that these final data are going to fall right into line."Mr. Evans continued, "We are well aware of the significant impact Kevetrin can provide to patients ...
Marketwire ALEXANDRIA, VA--(Marketwire - August 24, 2010) - Thentent=stemcell&utm_campaign=ADV">American Diabetes Association is extremely disappointed by the federal district court decision ...
... better understanding and treatment of psychiatric disorders. As always, the committee was challenged in its selection process and ultimately extremely proud to recommend and support these 42 brilliant, ...

Get Free Email and Phone News Alerts

* Your email address:
* Preferred Format:
* Enter the security code shown:
 
Home | Privacy Policy
© 2010 BioMedReports.com. All rights reserved